“…as large-cap pharmaceutical companies move to fill big holes… there are relatively few companies within the biotech industry that have large enough market caps to make a difference. You can buy anything within the biotech industry above a billion dollars and it will likely be a takeover candidate sometime in the next year or two.”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”